Devaux A, Beniuga G, Delree P, Quaghebeur C, et al. Evaluation of short-course durvalumab combined with dose-dense EC in the neoadjuvant setting for locally advanced luminal B/HER2(-) or triple-negative breast cancer. Breast Cancer Res 2025;27:212.
PMID: 41316390